APOC3 and cardiovascular disorder: Our objective was to elucidate the regulatory role of apoC-III in this more physiologically relevant situation and thereby gain better insight into the potential for therapeutic interventions targeted at apoC-III to alter circulating levels of TRLs and their remnants and so potentially protect against cardiovascular disease (5–9).